insights_auto
Why is IKT up 3,14%?
Dive Deeperchevron_right
IKT:NASDAQ
Inhibikase Therapeutics Inc
1,97 $
arrow_upward
+3,14%(+0,060) 1D
1,97 $
0,00% (0,00)
bedtimeAfter hours
Closed: 9 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IKT...
Open
1,90 $
High
1,98 $
Low
1,87 $
Mkt. cap
274,89 млн
Avg. vol.
518,16 м.
Volume
435,03 м.
52-wk high
2,61 $
52-wk low
1,33 $
EPS
-0,44 $
Beta
0,89
Shares outstanding
139,54 млн
No. of employees
35
Open
1,90 $
High
1,98 $
Low
1,87 $
Mkt. cap
274,89 млн
Avg. vol.
518,16 м.
Volume
435,03 м.
52-wk high
2,61 $
52-wk low
1,33 $
EPS
-0,44 $
Beta
0,89
Shares outstanding
139,54 млн
No. of employees
35
News stories
From web sources and news partners
PR Newswire
·
12 минут бұрын
Evernorth Completes Business Combination with Armada Acquisition Corp. II
Business Wire
·
58 минут бұрын
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
GuruFocus
·
41 минут бұрын
Nasdaq CEO Flags Tens of Billions in New Wall Street Opportunity
Yahoo Finance
·
5 сағат бұрын
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
Sector-
Websiteinhibikase.com